310 related articles for article (PubMed ID: 15333595)
1. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
[TBL] [Abstract][Full Text] [Related]
2. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
[TBL] [Abstract][Full Text] [Related]
3. A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive.
Brady BM; Amory JK; Perheentupa A; Zitzmann M; Hay CJ; Apter D; Anderson RA; Bremner WJ; Pollanen P; Nieschlag E; Wu FC; Kersemaekers WM
Hum Reprod; 2006 Jan; 21(1):285-94. PubMed ID: 16172147
[TBL] [Abstract][Full Text] [Related]
4. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
5. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
Anderson RA; Kinniburgh D; Baird DT
J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
[TBL] [Abstract][Full Text] [Related]
6. Suppression of spermatogenesis by testosterone enanthate in Thai men.
Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
[TBL] [Abstract][Full Text] [Related]
7. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
Kinniburgh D; Anderson RA; Baird DT
J Androl; 2001; 22(1):88-95. PubMed ID: 11191092
[TBL] [Abstract][Full Text] [Related]
8. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.
Kinniburgh D; Zhu H; Cheng L; Kicman AT; Baird DT; Anderson RA
Hum Reprod; 2002 Jun; 17(6):1490-501. PubMed ID: 12042267
[TBL] [Abstract][Full Text] [Related]
9. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men.
Sukcharoen N; Aribarg A; Kriangsinyos R; Chanprasit Y; Ngeamvijawat J
J Med Assoc Thai; 1996 Dec; 79(12):767-73. PubMed ID: 9071080
[TBL] [Abstract][Full Text] [Related]
12. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
[TBL] [Abstract][Full Text] [Related]
13. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
15. Suppression of human spermatogenesis by testosterone implants.
Handelsman DJ; Conway AJ; Boylan LM
J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
[TBL] [Abstract][Full Text] [Related]
16. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone.
Anderson RA; Van Der Spuy ZM; Dada OA; Tregoning SK; Zinn PM; Adeniji OA; Fakoya TA; Smith KB; Baird DT
Hum Reprod; 2002 Nov; 17(11):2869-77. PubMed ID: 12407041
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive efficacy of a depot progestin and androgen combination in men.
Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
[TBL] [Abstract][Full Text] [Related]
19. Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men.
Martin CW; Riley SC; Everington D; Groome NP; Riemersma RA; Baird DT; Anderson RA
Hum Reprod; 2000 Jul; 15(7):1515-24. PubMed ID: 10875859
[TBL] [Abstract][Full Text] [Related]
20. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
